We assessed the development of drug resistance in women exposed to antiretroviral
therapy (ART) for prevention of mother-to-child transmission (PMTCT) after 24 weeks …

Background: Pregnancy-limited antiretroviral therapy (PLAT) drastically reduces HIV-1
transmission to the newborn, but may select for antiretroviral drug resistance mutations in …

The objective of this study was to assess the resistance baseline in HIV-1-infected pregnant
women in China and the emergence of drug resistance (DR) among them and their infants …

There is broad consensus on an approach to preventing mother-to-child transmission, which
provides antiretroviral treatment in pregnancy and beyond to those women who need it, and …

Objective: The objective of this study is to assess nevirapine (NVP) resistance in infants who
became infected in the three arms of the Breastfeeding, Antiretrovirals and Nutrition (BAN) …

A retrospective, blinded study was conducted to examine the prevalence of antiretroviral
drug resistance among a cohort of HIV-infected infants born in 1998 and 1999 in New York …

Zidovudine monotherapy is used to reduce perinatal HIV transmission in women with low
viral loads. There are few data on the risk of drug resistance in this select cohort of women …

Background A single intrapartum dose of nevirapine for the prevention of mother-to-child
transmission of human immunodeficiency virus (HIV) leads to the selection of resistance …

The provision of antiretroviral drugs for the prevention of mother-to-child HIV transmission
has been rising sharply in low-and middle-income countries. Changes to the World Health …

Objectives: To report perinatal transmission of multidrug resistant (MDR) HIV related to
variable maternal adherence antenatally. Methods: Case study including review of clinic …